- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02124720
Using Mobile Technology to Reduce Stereotypy
24. september 2019 opdateret af: Marc Lanovaz, Université de Montréal
Using Mobile Technology to Reduce Stereotypy in Children With Autism Spectrum Disorders
Nearly all children with autism spectrum disorders engage in non-functional repetitive vocal and motor behaviours commonly referred to as stereotypy.
These repetitive behaviours may considerably interfere with the child's daily functioning, learning, and social inclusion.
As such, stereotypy generally has a negative impact on the child and family's health and quality of life.
Several behavioural interventions have been developed to reduce engagement in stereotypy in children with autism spectrum disorders, but the limited number of specialists available, the long waiting lists associated with public health services in Canada, and the high costs of private services have considerably restricted accessibility.
One potential solution to the limited availability and high costs of services is using a mobile application to recommend, teach, and monitor interventions designed to reduce engagement in stereotypy.
To this end, the purpose of the study is to evaluate the effects of the iSTIM (i.e., individualized Stereotypy Treatment Integrated Modules), a mobile application designed to assist parents in reducing stereotypy in children with autism spectrum disorders.
Specifically, we will assess whether the iSTIM correctly estimates the frequency or duration of stereotypy, offers suggestions consistent with recommended clinical practices, effectively reduces engagement in stereotypy, and is socially acceptable, safe, and easy to use for parents of children with autism spectrum disorders.
The results of the study will allow us to determine whether the mobile application may be used to treat this core symptom in children with autism spectrum disorders, which could potentially reduce waiting times and costs of providing health services to this population.
By reducing engagement in stereotypy, the iSTIM may also promote and facilitate the social participation as well as improve the quality of life and health of children with autism spectrum disorders and their families.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
39
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Ontario
-
Mississauga, Ontario, Canada, L5L 5Y6
- Monarch House
-
-
Quebec
-
Montreal, Quebec, Canada, H8R 2H1
- CRDITED de Montréal
-
Montreal, Quebec, Canada
- Gold Centre
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
Ikke ældre end 12 år (Barn)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Clinical diagnosis of autism spectrum disorders
- Must engage in at least one form of stereotypy
Exclusion Criteria:
- Stereotypy occurs less than 12 times per hour (or less than 20% of time)
- The form of stereotypy is potentially dangerous for the person (e.g., head banging, self-biting)
- The form of stereotypy is maintained by social consequences (e.g., attention, task avoidance)
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Mobile application
Use of the iSTIM mobile application 2 to 4 times per week over approximately 8 to 16 weeks
|
Trained research assistants and parents will implement the assessments and interventions recommended by the iSTIM mobile application during sessions lasting between 10 and 60 minutes
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Frequency and duration of stereotypy
Tidsramme: 2 to 4 times per week over 8 to 16 weeks
|
Direct observation of the frequency and duration of stereotypy during 10- to 60-minute sessions
|
2 to 4 times per week over 8 to 16 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Social validity score
Tidsramme: Immediately following the end of the intervention (i.e., after 8 to 16 weeks)
|
The user responds to a social validity questionnaire
|
Immediately following the end of the intervention (i.e., after 8 to 16 weeks)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Marc J Lanovaz, Ph.D., Université de Montréal
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. december 2014
Primær færdiggørelse (Faktiske)
1. februar 2019
Studieafslutning (Faktiske)
1. februar 2019
Datoer for studieregistrering
Først indsendt
24. april 2014
Først indsendt, der opfyldte QC-kriterier
24. april 2014
Først opslået (Skøn)
28. april 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
26. september 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
24. september 2019
Sidst verificeret
1. september 2019
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CERFAS-2014-15-030-P
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med iSTIM
-
BlueWind MedicalAfsluttetBehandling af patienter, der lider af overaktiv blære (OAB)Forenede Stater, Belgien, Holland, Det Forenede Kongerige
-
University of California, Los AngelesAfsluttetOveraktiv blære | Urgency-frekvens syndrom | Urinhyppighed mere end én gang om nattenForenede Stater